Close

Hemispherx Biopharma (HEB) Completes Upgrades to New Brunswick Facility

March 2, 2015 8:42 AM EST Send to a Friend
Hemispherx Biopharma (AMEX: HEB) announced that its manufacturing site located in New Brunswick, New Jersey, presently configured at over 43,000 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login